HB1678
To Amend The Abortion-inducing Drugs Safety Act To Increase The Criminal Penalties And Clarify The Civil Penalties.
Last Action (March 4, 2025): Recommended for study in the Interim by the Committee on JUDICIARY COMMITTEE- HOUSE
Sponsors
AI-Generated Summary
House Bill 1678 amends the Arkansas Abortion-Inducing Drugs Safety Act to increase criminal penalties and clarify civil remedies for violations. The bill upgrades the criminal classification for violating the act from a Class A misdemeanor to a Class D felony. It imposes a $50,000 fine per violation for licensed healthcare providers, pharmacists, or entities that prescribe or authorize the sale or delivery of abortion-inducing drugs in violation of the subchapter. The bill expands the grounds for civil litigation, allowing the woman, the father, or specified relatives to sue for damages, and permits the Attorney General or local prosecutors to bring legal action. It also classifies such violations as deceptive and unconscionable trade practices under the state's Deceptive Trade Practices Act. Additionally, the bill mandates that the Arkansas State Medical Board must revoke the medical license of any physician found to be in non-compliance with the subchapter.
Potential Impact Analysis
Who Might Benefit?
The primary beneficiaries of this legislation are individuals or groups who advocate for more stringent enforcement of anti-abortion laws, including those who wish to restrict access to abortion-inducing drugs through enhanced legal and professional deterrents. Specifically, the bill empowers the Attorney General, local prosecuting attorneys, and private individuals such as the father of the unborn child or family members of a pregnant woman to initiate legal actions against providers, thereby potentially increasing their ability to influence or challenge medical practices regarding abortion-inducing drugs.
Who Might Suffer?
The entities most negatively impacted by this bill are licensed healthcare providers, pharmacists, and medical facilities that prescribe or distribute abortion-inducing drugs, as they face increased risk of felony criminal charges, substantial financial penalties of $50,000 per violation, mandatory loss of medical licensure, and the threat of civil litigation. Furthermore, patients seeking access to these drugs may be negatively impacted by a reduction in the availability of medical services, as providers may stop offering these prescriptions due to the heightened legal and financial risks associated with compliance.
Get Notified
Receive an email when this bill's status changes.